USE OF HALOGENATED SULFONATES AS A STABILIZER BOOSTER IN PVC

Details for Australian Patent Application No. 2002325317 (hide)

Owner AKZO NOBEL N.V.

Inventors VAN DER KOLK, Johannes, Cornelis; SCHMETS, Gerard, Hubert, Frans; HUISMAN, Hendrik, Willem; HARVEY, Heather, Blue; VAN ES, Daniel, Stephan; VAN HAVEREN, Jacco; FRISSEN, Augustinus, Emmanuel

Pub. Number AU-A-2002325317

PCT Number PCT/EP02/07687

PCT Pub. Number WO2003/016390

Priority 60/312,641 15.08.01 US; 60/332,235 16.11.01 US

Filing date 10 July 2002

Wipo publication date 3 March 2003

International Classifications

C08K 005/42 Use of organic ingredients

C08K 013/02 Use of mixtures of ingredients not covered by any single one of main groups , each of these compounds being essential

C08L 027/06 Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/312,641 15.08.01 US; 60/332,235 16.11.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002325317

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325318-GENERATOR FOR UNITARY POWER FACTOR ARC WELDERS

2002325316-8-methoxy-(1,2,4)triazolo(1,5-A)pyridine derivatives and their use as adenosine receptor ligands